| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Simon R Bramhall | Q117812106 |
| P2093 | author name string | Simon G Fisher | |
| Moustafa Mabrouk Mourad | |||
| Richard P T Evans | |||
| P2860 | cites work | Epidemiology of esophageal cancer | Q24625927 |
| The Vienna classification of gastrointestinal epithelial neoplasia | Q24669885 | ||
| Efficacy and durability of radiofrequency ablation for Barrett's Esophagus: systematic review and meta-analysis | Q26821767 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review | Q33716660 | ||
| Is there publication bias in the reporting of cancer risk in Barrett's esophagus? | Q33993884 | ||
| Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy | Q34028377 | ||
| Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group | Q34059633 | ||
| American Gastroenterological Association medical position statement on the management of Barrett's esophagus | Q34168686 | ||
| Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis | Q34352867 | ||
| British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus | Q34380645 | ||
| Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry | Q34642545 | ||
| Meta analysis: Cancer risk in Barrett's oesophagus. | Q34694561 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis | Q34786281 | ||
| Barrett esophagus and risk of esophageal cancer: a clinical review | Q34940151 | ||
| Observer variation in the diagnosis of superficial oesophageal adenocarcinoma | Q34960762 | ||
| Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study | Q35027021 | ||
| Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States | Q35114043 | ||
| Gastro-esophageal reflux disease symptoms and demographic factors as a pre-screening tool for Barrett's esophagus. | Q35149279 | ||
| Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus | Q35595358 | ||
| American Gastroenterological Association technical review on the management of Barrett's esophagus | Q35673305 | ||
| Validation of the Prague C & M criteria for the endoscopic grading of Barrett's esophagus by gastroenterology trainees: a multicenter study | Q35991301 | ||
| Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis | Q36190840 | ||
| Application of the Prague C and M criteria for endoscopic description of columnar-lined esophagus in South Korea | Q36809873 | ||
| The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review. | Q36860466 | ||
| Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium | Q37297394 | ||
| Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review | Q37379015 | ||
| Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia | Q37540092 | ||
| Definition of Barrett's esophagus: time for a rethink--is intestinal metaplasia dead? | Q37558153 | ||
| Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis | Q37619801 | ||
| Barrett's esophagus: a review of the literature | Q37861001 | ||
| The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis | Q37945514 | ||
| The impact of laparoscopic anti-reflux surgery in patients with Barrett's esophagus | Q38220732 | ||
| Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel | Q38230762 | ||
| Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial | Q38433659 | ||
| Effect of antireflux surgery for Barrett's esophagus: long-term results | Q38774834 | ||
| Continuing rapid increase in esophageal adenocarcinoma in England and Wales | Q39171596 | ||
| Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma | Q40795341 | ||
| Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry | Q41362301 | ||
| Validation of a new approach for mortality risk assessment in oesophagectomy for cancer based on age- and gender-corrected body mass index. | Q41616674 | ||
| Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus | Q43589311 | ||
| The application of Prague C and M criteria in the diagnosis of Barrett's esophagus in an ethnic Chinese population | Q43617210 | ||
| Risk factors in the development of esophageal adenocarcinoma | Q44008997 | ||
| Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results | Q45062919 | ||
| High definition versus standard definition white light endoscopy for detecting dysplasia in patients with Barrett's esophagus | Q45330160 | ||
| Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis | Q46667000 | ||
| Does methylene blue detect intestinal metaplasia in Barrett's esophagus? | Q48004074 | ||
| Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. | Q48736100 | ||
| A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus | Q50463490 | ||
| Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study | Q50505120 | ||
| Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection. | Q52880496 | ||
| Progression or regression of Barrett's esophagus--is it all in the eye of the beholder? | Q52958021 | ||
| Esophageal Cancer | Q56209683 | ||
| Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients With Barrett's Esophagus | Q57259755 | ||
| The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria | Q58104636 | ||
| The role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus | Q59705210 | ||
| Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus | Q73793513 | ||
| Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus | Q74564550 | ||
| Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy | Q74731664 | ||
| Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria | Q74794748 | ||
| Unsedated transnasal endoscopy accurately detects Barrett's metaplasia and dysplasia | Q77149858 | ||
| French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett's esophagus | Q80805524 | ||
| Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error | Q81135185 | ||
| Lower esophageal palisade vessels and the definition of Barrett's esophagus | Q81224556 | ||
| High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study | Q81273794 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus | Q83662624 | ||
| Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study | Q86510342 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | 47 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | esophagus | Q173710 |
| esophagectomy | Q298191 | ||
| esophagoscopy | Q298196 | ||
| adenocarcinoma | Q356033 | ||
| proton-pump inhibitor | Q421704 | ||
| Barrett's esophagus | Q808892 | ||
| watchful waiting | Q2161551 | ||
| esophageal neoplasm | Q56014520 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 10316-10324 | |
| P577 | publication date | 2016-12-01 | |
| 2016-12-21 | |||
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Evolving management of metaplasia and dysplasia in Barrett's epithelium | |
| P478 | volume | 22 |
| Q64101183 | Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma |
| Q91934234 | Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype |
| Q94602422 | Recent advances in understanding and preventing oesophageal cancer |
Search more.